Upgrade to SI Premium - Free Trial

Oscar Health Inc (OSCR) PT Raised to $30 at Barclays

May 27, 2026 2:27 AM
Barclays analyst Andrew Mok raised the price target on Oscar Health Inc (NYSE: OSCR) to $30.00 (from $21.00) while maintaining a Equalweight rating.

Categories

Analyst PT Change